Grant Angus
SEC CIK 1988830 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP, Business Development | 8,848 | — | $70.2K | 2 | 2024-08-09 | 2024-08-09 |
Most active insiders at TEVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Francis Richard D | Pres, CEO | — | $31.26M |
| 2 | MIGNONE ROBERTO | Dir | — | $22.82M |
| 3 | Kalif Eliyahu Sharon | EVP, CFO | — | $20.72M |
| 4 | Sabag Mark | See "Remarks" | — | $13.15M |
| 5 | Daniell Richard | EVP, European Commercial | — | $12.08M |
| 6 | Hughes Eric A | See "Remarks" | — | $4.17M |
| 7 | Fox Christine | EVP, U.S. Commercial | — | $2.75M |
| 8 | Lippman Evan | EVP, Business Development | — | $2.16M |
| 9 | Weiss Amir | CAO | — | $1.41M |
| 10 | Shields Matthew | EVP, Gbl Ops | — | $1.40M |
Grant Angus made no open-market trades at TEVA in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-08-13 | 2024-08-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Grant Angus | EVP, Business Development | S - Sale+OE | $17.28 | -4,065 | 8,848 | -31% | -$70.2K |
| DT | 2024-08-13 | 2024-08-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Grant Angus | EVP, Business Development | M - OptEx | — | +12.9K | 12.9K | New | — |
Purchase Sale Sale after option exercise All abbreviations